These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 31126248)

  • 1. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
    Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
    BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minnelide combined with Angptl3 knockout completely protects mice with adriamycin nephropathy via suppression of TGF-β1-Smad2 and p53 pathways.
    Ji B; Liu J; Ma Y; Yin Y; Xu H; Shen Q; Yu J
    Int Immunopharmacol; 2023 Feb; 115():109656. PubMed ID: 36608441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy.
    Asanuma K; Akiba-Takagi M; Kodama F; Asao R; Nagai Y; Lydia A; Fukuda H; Tanaka E; Shibata T; Takahara H; Hidaka T; Asanuma E; Kominami E; Ueno T; Tomino Y
    Am J Nephrol; 2011; 33(6):537-49. PubMed ID: 21606645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel role of angiopoietin-like-3 associated with podocyte injury.
    Liu J; Gao X; Zhai Y; Shen Q; Sun L; Feng C; Rao J; Liu H; Zha X; Guo M; Ma D; Zhang Z; Li R; Xu H
    Pediatr Res; 2015 Jun; 77(6):732-9. PubMed ID: 25710887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Importin- α -Mediated Nuclear Localization of Dendrin Attenuates Podocyte Loss and Glomerulosclerosis.
    Empitu MA; Kikyo M; Shirata N; Yamada H; Makino SI; Kadariswantiningsih IN; Aizawa M; Patrakka J; Nishimori K; Asanuma K
    J Am Soc Nephrol; 2023 Jul; 34(7):1222-1239. PubMed ID: 37134307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.
    Lv Q; Han X; Ni J; Ma Q; Dai R; Liu J; Liu J; Zhai Y; Shen Q; Sun L; Liu H; Rao J; Xu H
    Cell Death Dis; 2022 Oct; 13(10):867. PubMed ID: 36229446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-proteinuria effect of antibody against ANGPTL3 coil-coiled domain on adriamycin-induced nephropathy in mice.
    Han X; Dai R; Zhai Y; Shen Q; Sun L; Liu H; Xu H
    Biochem Biophys Res Commun; 2019 Aug; 516(3):812-818. PubMed ID: 31256934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
    Marshall CB; Krofft RD; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin.
    Qiu Y; Lei C; Zeng J; Xie Y; Cao Y; Yuan Q; Su H; Zhang Z; Zhang C
    Mol Ther; 2023 Nov; 31(11):3337-3354. PubMed ID: 37689970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte protection by Angptl3 knockout via inhibiting ROS/GRP78 pathway in LPS-induced acute kidney injury.
    Ma Y; Liu J; Liu H; Han X; Sun L; Xu H
    Int Immunopharmacol; 2022 Apr; 105():108549. PubMed ID: 35086056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiopoietin-like protein 3 regulates the motility and permeability of podocytes by altering nephrin expression in vitro.
    Gao X; Xu H; Liu H; Rao J; Li Y; Zha X
    Biochem Biophys Res Commun; 2010 Aug; 399(1):31-6. PubMed ID: 20633534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis.
    Guo J; Ananthakrishnan R; Qu W; Lu Y; Reiniger N; Zeng S; Ma W; Rosario R; Yan SF; Ramasamy R; D'Agati V; Schmidt AM
    J Am Soc Nephrol; 2008 May; 19(5):961-72. PubMed ID: 18256352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
    Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
    Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of cyclosporine A and minocycline on mitochondrial disequilibrium-related podocyte injury and proteinuria occurrence induced by adriamycin.
    Guan N; Ren YL; Liu XY; Zhang Y; Pei P; Zhu SN; Fan Q
    Nephrol Dial Transplant; 2015 Jun; 30(6):957-69. PubMed ID: 25646018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-9 protects from early podocyte injury and progressive glomerulosclerosis in Adriamycin-induced nephropathy.
    Xiong T; Attar M; Gnirck AC; Wunderlich M; Becker M; Rickassel C; Puelles VG; Meyer-Schwesinger C; Wiech T; Nies JF; Divivier M; Fuchs T; Schulze Zur Wiesch J; Taipaleenmäki H; Hoxha E; Wirtz S; Huber TB; Panzer U; Turner JE
    Kidney Int; 2020 Sep; 98(3):615-629. PubMed ID: 32446933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with telmisartan and oxacalcitriol suppresses the progression of murine adriamycin nephropathy.
    Jeong KH; Asanuma K; Lydia A; Takagi M; Asao R; Kodama F; Asanuma E; Tomino Y
    Nephron; 2015; 129(2):143-54. PubMed ID: 25661164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of C/EBP-α in Adriamycin-induced podocyte injury.
    Zhong F; Wang W; Lee K; He JC; Chen N
    Sci Rep; 2016 Sep; 6():33520. PubMed ID: 27644413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
    Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
    Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IP
    Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
    BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.